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Shandong Wu1,4, Susan P. Weinstein1, Michael J. DeLeo1, Emily F. Conant1, Jinbo Chen2, Susan M. Domchek3
and Despina Kontos1*Erratum
With this erratum, we would like to clarify key differences
between our current publication [1], and prior work pub-
lished in the American Journal of Roentgenology (AJR)
and cited as reference [33] (reference [2] here), from
which our current study includes a subset of the patient
population. First, this prior work was a qualitative reader
study, in which fibroglandular tissue (FGT) and back-
ground parenchymal enhancement (BPE) were evaluated
subjectively using visual assessment by two clinical readers
into the four qualitative Breast Imaging Reporting and
Data System (BI-RADS) categories. In contrast, in our
study published in Breast Cancer Research (BCR), we per-
formed quantitative analysis, using a fully-automated
computerized method developed by our group, reported
for the first time for quantifying BPE in breast MRI, where
a key aspect for BPE quantification, the optimal evaluation
and determination for the parameter of enhancement ra-
tio (R%), was also investigated in association to patient
cancer outcomes. In addition to evaluating group-wise
changes in the means of FGT and BPE between pre-
and post- risk-reducing salpingo-oophorectomy
(RRSO), we also included a comparison of the effect for
BPE assessed in three sequential post-contrast se-
quences acquired at different time-points, and most im-
portantly conducted an additional evaluation of
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sures post RRSO, which was not evaluated in the AJR
study. This is a key investigation, as predicting subsequent
breast cancer is the main outcome of interest for improv-
ing clinical-decision making for risk-evaluation and risk-
reduction management of women with BRCA mutations.
The quantitative analysis reported in our study published
in BCR has shown overall superior performance to the
prior qualitative study published in AJR, providing a po-
tential precision-medicine approach for the quantification
of MRI BPE as a biomarker for guiding risk-reduction
management in women at high-risk for breast cancer.
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